Showing results (11-20 of 39) with videos related to

Sort By:
Pageof 4
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 30, 2011
Population-based patterns and predictors of prostate-specific antigen screening among older men in the United StatesMichael W Drazer, Dezheng Huo, Mara A Schonberg, et al.
Journal of Genetic Counseling|January 15, 2023
Stagnation in quality of next-generation sequencing assays for the diagnosis of hereditary hematopoietic malignanciesGregory W Roloff, Reid Shaw, Timothy E O'Connor, et al.
Current Hematologic Malignancy Reports|September 28, 2018
Hereditary Myelodysplastic Syndrome and Acute Myeloid Leukemia: Diagnosis, Questions, and ControversiesImo J Akpan, Afaf E G Osman, Michael W Drazer, et al.
Leukemia & Lymphoma|June 9, 2023
Clinical guideline variability in the diagnosis of hereditary hematopoietic malignancy syndromesAdam Hamidi, Gregory W Roloff, Reid Shaw, et al.
Expert Review of Anticancer Therapy|April 15, 2016
Stereotactic body radiotherapy for oligometastatic breast cancer: a new standard of care, or a medical reversal in waiting?Michael W Drazer, Joseph K Salama, Olwen M Hahn, et al.
Traffic (Copenhagen, Denmark)|June 9, 2007
Light chain C-terminal region reinforces the stability of clathrin heavy chain trimersJoel A Ybe, Samantha Perez-Miller, Qian Niu, et al.
Blood Advances|September 7, 2021
Therapy-related myeloid neoplasms in 109 patients after radiation monotherapyAnand Ashwin Patel, Alexandra E Rojek, Michael W Drazer, et al.
Stem Cell Research|February 5, 2026
Generation of an induced pluripotent stem cell line CGOi001-A from a patient with hereditary thrombocytopenia and a germline ANKRD26 mutationAubrianna S Ramsland, Karolina Dudek, Kelsey E McNeely, et al.
Stem Cell Reports|May 21, 2021
Study of inherited thrombocytopenia resulting from mutations in ETV6 or RUNX1 using a human pluripotent stem cell modelSara Borst, Catriana C Nations, Joshua G Klein, et al.
Pageof 4